Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Sees Large Volume Increase – Should You Buy?

Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) saw an uptick in trading volume on Thursday. Approximately 750 shares changed hands during mid-day trading, an increase of 275% from the previous session’s volume of 200 shares. The stock last traded at $58.79 and had previously closed at $60.00.

Recordati Industria Chimica E Farmaceutica Trading Down 2.0%

The stock has a fifty day moving average price of $58.00 and a 200 day moving average price of $57.77. The stock has a market cap of $12.13 billion, a PE ratio of 20.97 and a beta of 0.25. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.86 and a current ratio of 1.26.

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.91 earnings per share for the quarter. The business had revenue of $810.70 million for the quarter. Recordati Industria Chimica E Farmaceutica had a net margin of 18.38% and a return on equity of 33.73%.

Recordati Industria Chimica E Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A. is an Italian pharmaceutical company focused on the research, development, manufacture and commercialization of medicines. Its activities are centered on specialty-care and rare-disease treatments, with products addressing areas such as endocrinology, oncology, urology, cardiology, gastroenterology and other specialized medical needs.

The company markets both proprietary and licensed medicines, serving patients through prescription products and therapies for uncommon or underserved conditions.